Brain's Waste System Could Clear Parkinson's Toxic Proteins
New research reveals how targeting the brain's glymphatic drainage system might remove harmful α-synuclein buildup in Parkinson's disease.
Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
109 articles
New research reveals how targeting the brain's glymphatic drainage system might remove harmful α-synuclein buildup in Parkinson's disease.
Large study finds genetic background doesn't explain mitochondrial damage in neurodegenerative disease, pointing to complex causes.
Editorial raises concerns about influential 2009 study on Cerebrolysin's effects on brain degeneration in Alzheimer's models.
New research reveals how declining brain lymphatic drainage contributes to Alzheimer's and Parkinson's disease vulnerability.
New research reveals that 32% of early Alzheimer's patients also have alpha-synuclein protein aggregates, linked to smell loss.
Following Mediterranean or MIND diets for decades significantly reduced dementia risk and slowed cognitive aging in 130,000+ adults.
New research identifies WDR12 and HIVEP3 genes as key contributors to exceptional cognitive preservation in elderly Amish individuals.
New research reveals how acetylcholine controls whether dopamine enhances learning or physical vigor in the brain.
Advanced brain imaging reveals how Parkinson's damages the brain's arousal center, explaining fatigue and cognitive issues beyond movement problems.
International autopsy study of 7,309 brains shows Lewy body pathology in 27% of elderly, with distinct patterns by sex and brain region.
Major study reveals how genetic variants create distinct vulnerability patterns for dementia in Lewy body diseases like Parkinson's.
New review reveals how gut microbiome changes could initiate Parkinson's pathology years before motor symptoms, offering prevention targets.